What this study is
The goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aims to answer is: does peer recovery support improve retention in medication treatment for opioid use disorder?
Researchers will compare two groups: (1) standard care combined with a peer recovery support program, and (2) standard care alone, to see if peer recovery support works to improve retention in medication treatment for opioid use disorder.
Participants will: visit clinics as they normally would to receive standard care (medication treatment for opioid use disorder); complete two questionnaires - one when they start treatment and one 6 months later; and agree to let researchers use information from their medical record. Participants in group 1 will also be invited to meet with a peer recovery support specialist for up to 6 months.
What's being tested
- Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment
Intervention · BEHAVIORAL
The intervention adds a peer recovery support (PRS) program to standard outpatient medication for opioid use disorder treatment and medical care. The PRS program will entail meeting one-on-one with a peer recovery specialist over a 6-month period, who will utilize their lived experience with substance use and recovery to provide emotional, informational, instrumental, and affiliational support to participants.
Study details
- Sponsor
- Geisinger Clinic
- Conditions
- Opioid Use Disorder
- Enrolling
- 218 people
- Starts
- 2025-12-23
- Est. completion
- 2029-07-31
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 89 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Adult ≥ 18 years of age
- Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic
- Willing and able to give informed consent
You can't join if
- Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date
- Not proficient in English
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openGeisinger Clinic
Danville, Pennsylvania, United States
- Melissa N Poulsen, PhD, MPH · Principal investigator
Recruiting
Study team
Sponsor
Geisinger Clinic
Study ID R33DA059880-02
Principal investigator
Melissa Poulsen, PhD
Geisinger Clinic
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.